The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| 89BIO INC | COM | 282559103 | 695,179 | 95,623 | SH | SOLE | 95,623 | 0 | 0 | |||
| ADMA BIOLOGICS INC | COM | 000899104 | 45,980,033 | 2,317,542 | SH | SOLE | 2,317,542 | 0 | 0 | |||
| AKERO THERAPEUTICS INC | COM | 00973Y108 | 9,816,400 | 242,500 | SH | SOLE | 242,500 | 0 | 0 | |||
| APOGEE THERAPEUTICS INC | COM | 03770N101 | 1,120,800 | 30,000 | SH | SOLE | 30,000 | 0 | 0 | |||
| ASSEMBLY BIOSCIENCES INC | COM NEW | 045396207 | 1,912,000 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | |||
| AURA BIOSCIENCES INC | COM | 05153U107 | 2,769,295 | 472,576 | SH | SOLE | 472,576 | 0 | 0 | |||
| BIONTECH SE | SPONSORED ADS | 09075V102 | 1,365,900 | 15,000 | SH | SOLE | 15,000 | 0 | 0 | |||
| CELLECTIS S A | SPON ADS | 15117K103 | 4,038,061 | 3,256,501 | SH | SOLE | 3,256,501 | 0 | 0 | |||
| CORVUS PHARMACEUTICALS INC | PUT | 221015950 | 286,200 | 90,000 | SH | Put | SOLE | 90,000 | 0 | 0 | ||
| INSMED INC | COM PAR $.01 | 457669307 | 20,026,125 | 262,500 | SH | SOLE | 262,500 | 0 | 0 | |||
| IOVANCE BIOTHERAPEUTICS INC | COM | 462260100 | 4,995,000 | 1,500,000 | SH | SOLE | 1,500,000 | 0 | 0 | |||
| ORUKA THERAPEUTICS INC | COM | 687604108 | 597,286 | 58,215 | SH | SOLE | 58,215 | 0 | 0 | |||
| PRAXIS PRECISION MEDICINES I | COM NEW | 74006W207 | 719,530 | 19,000 | SH | SOLE | 19,000 | 0 | 0 | |||
| SIGHT SCIENCES INC | COM | 82657M105 | 2,000,640 | 833,600 | SH | SOLE | 833,600 | 0 | 0 | |||
| SPYRE THERAPEUTICS INC | COM NEW | 00773J202 | 1,129,450 | 70,000 | SH | SOLE | 70,000 | 0 | 0 | |||
| TAYSHA GENE THERAPIES INC | COM SHS | 877619106 | 1,745,223 | 1,255,556 | SH | SOLE | 1,255,556 | 0 | 0 | |||
| ULTRAGENYX PHARMACEUTICAL IN | COM | 90400D108 | 1,719,975 | 47,500 | SH | SOLE | 47,500 | 0 | 0 | |||
| ULTRAGENYX PHARMACEUTICAL IN | CALL | 90400D908 | 1,361,496 | 37,600 | SH | Call | SOLE | 37,600 | 0 | 0 | ||
| ZAI LAB LTD | ADR | 98887Q104 | 14,456,000 | 400,000 | SH | SOLE | 400,000 | 0 | 0 | |||